MoticEasyScan systems are now certified for clinical use in Canada, allowing pathologists there to use the diagnostic tools to scan, share, and use whole-slide images for primary diagnosis. This product line of whole-slide scanners from Motic, a provider of digital pathology solutions based in Vancouver, Canada, recently received a Health Canada Class II Medical Device License. 

According to the company, MoticEasyScan solutions are designed to address one of the largest remaining barriers to entry into the digital pathology workflow: cost of ownership. Digital pathology is widely acknowledged as an essential technology to improve patient care, reduce diagnosis time, and to support pathologists with flexible and easy access to the tools required to improve healthcare outcomes. However, stakeholders, hospitals, and their partners have struggled to accommodate what can be an overwhelming cost to implement a digital pathology solution. 

Given the historically high cost of whole-slide scanning systems, initiatives to implement the technology are challenged by lengthy in-depth analysis projects to support the business case and investment in the technology. With Health Canada Class II Medical Device approval, MoticEasyScan whole-slide scanners offer a cost-effective pathway to support these efforts while also providing a pathway for future expansion.

According to the company, Motic focuses on affordability and streamlining adoption so that stakeholders can realize the benefits of digital work immediately. Customers can choose from solutions providing single-slide scanning through to high-volume slide-scanning capabilities.

Today’s shortage of pathology expertise around the globe is leaving many remote areas in vulnerable positions and constantly increasing the workload for active pathologists. With a digitized workflow, a pathologist can receive a patient’s slides within minutes instead of weeks. Frozen section samples can be read (and controlled) remotely in real-time, cutting arduous travel for the pathologist. Even global projects that were shut down due to recent travel restrictions can now safely continue on the cloud with digitally scanned biopsies.

“With this milestone of a Class II Medical Device License achieved in Canada, Motic will assist Canadian health system partners to fully realize the benefits of embracing digital pathology,” says Nicholas Chan, director of digital pathology for Motic. “It ultimately means easy remote access, faster turnaround time, better workflow efficiency, improved collaboration among colleagues around the world and, collectively, better healthcare for all.”

MoticEasyScan whole-slide scanning systems are available in Canada through Quorum Technologies Inc., which has been deploying digital pathology solutions in the country for more than 15 years.

“Quorum provides the vision, flexibility, dedication, and understanding of the digital pathology community, necessary to ensure longevity and adoption of digital pathology,” says John Arbuckle, president and CEO of Quorum Technologies Inc. “We are pleased to now be able to offer the MoticEasyScan whole-slide scanning systems as part of our integrated clinical solutions to improve patient care and assist pathologists with a truly functional workflow.”

For more information, visit Motic Digital Pathology.

Featured Image: The MoticEasyScan product line of whole-slide scanners from Motic, a provider of digital pathology solutions based in Vancouver, Canada, recently received a Health Canada Class II Medical Device License. Photo: Motic Digital Pathology